Meeting of the Tick-Borne Disease Working Group, 15165 [2018-07217]

Download as PDF 15165 Federal Register / Vol. 83, No. 68 / Monday, April 9, 2018 / Notices Number of respondents Form name Number of responses per respondent Total responses Average burden per response (in hours) Total burden hours Telehealth Resource Center Performance Data Collection Tool ................................................................................... 14 42 588 0.07 41 Total .............................................................................. 14 ........................ 588 ........................ 41 Dated: April 3, 2018. Lori Roche, Acting Deputy Director, Division of the Executive Secretariat. 4. Access to Care Services and Support to Patients; 5. Vaccine and Therapeutics; and 6. Other Tick-Borne Diseases and Coinfections. DATES: May 10, 2018, from 8:30 a.m. to 6:30 p.m., Eastern Time. ADDRESSES: This will be a virtual meeting that is held via webcast. Members of the public may attend the meeting via webcast. Instructions for attending this virtual meeting will be posted one week prior to the meeting at: https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/ index.html. [FR Doc. 2018–07175 Filed 4–6–18; 8:45 am] FOR FURTHER INFORMATION CONTACT: BILLING CODE 4165–15–P James Berger, Office of HIV/AIDS and Infectious Disease Policy, Office of the Assistant Secretary for Health, Department of Health and Human Services; via email at tickbornedisease@ hhs.gov or by phone at 202–795–7697. SUPPLEMENTARY INFORMATION: The Working Group invites public comment on issues related to the Working Group’s charge. Comments may be provided over the phone during the meeting or in writing. Persons who wish to provide comments by phone should review directions at https://www.hhs.gov/ash/ advisory-committees/tickbornedisease/ meetings/ before submitting a request via email at tickbornedisease@ hhs.gov on or before May 3, 2018. Phone comments will be limited to three minutes each to accommodate as many speakers as possible. A total of 60 minutes will be allocated to public comments. If more requests are received than can be accommodated, speakers will be randomly selected. The nature of the comments will not be considered in making this selection. Public comments may also be provided in writing. Individuals who would like to provide written comment should review directions at https://www.hhs.gov/ash/ advisory-committees/tickbornedisease/ meetings/ before sending their comments to tickbornedisease@ hhs.gov on or before May 3, 2018. Background and Authority: The TickBorne Disease Working Group was established on August 10, 2017, in accordance with section 2062 of the 21st Century Cures Act, and the Federal HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Tick-Borne Disease Working Group Office of HIV/AIDS and Infectious Disease Policy, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: The Department of Health and Human Services (HHS) announces the fourth ‘‘on-line’’ meeting of the TickBorne Disease Working Group (Working Group) on May 10, 2018, from 8:30 a.m. to 6:30 p.m., Eastern Time. For this fourth meeting, the Working Group will focus on the findings and basis for the draft reports from the work of the six Subcommittee Working Groups that were established on December 12, 2017. These subcommittees were established to assist the Working Group with the development of the report to Congress and the HHS Secretary as required by the 21st Century Cures Act. The subcommittees are: 1. Disease Vectors, Surveillance and Prevention (includes epidemiology of tick-borne diseases); 2. Pathogenesis, Transmission, and Treatment; 3. Testing and Diagnostics (including laboratory-based diagnoses and clinicaldiagnoses); sradovich on DSK3GMQ082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:06 Apr 06, 2018 Jkt 244001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 Advisory Committee Act, 5 U.S.C. App., as amended, to provide expertise and review all HHS efforts related to tickborne diseases to help ensure interagency coordination and minimize overlap, examine research priorities, and identify and address unmet needs. In addition, the Working Group will report to the Secretary and Congress on their findings and any recommendations for the federal response to tick-borne disease prevention, treatment, and research, and addressing gaps in those areas. Dated: April 2, 2018. James Berger, Office of HIV/AIDS and Infectious Disease Policy, Alternate Designated Federal Officer, Tick-Borne Disease Working Group. [FR Doc. 2018–07217 Filed 4–6–18; 8:45 am] BILLING CODE 4150–28–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Nursing Research; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Council for Nursing Research. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The journals as potential titles to be indexed by the National Library of Medicine and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the journals as potential titles to be indexed by the National Library of Medicine, the disclosure of E:\FR\FM\09APN1.SGM 09APN1

Agencies

[Federal Register Volume 83, Number 68 (Monday, April 9, 2018)]
[Notices]
[Page 15165]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-07217]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Tick-Borne Disease Working Group

AGENCY: Office of HIV/AIDS and Infectious Disease Policy, Office of the 
Assistant Secretary for Health, Office of the Secretary, Department of 
Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) announces 
the fourth ``on-line'' meeting of the Tick-Borne Disease Working Group 
(Working Group) on May 10, 2018, from 8:30 a.m. to 6:30 p.m., Eastern 
Time. For this fourth meeting, the Working Group will focus on the 
findings and basis for the draft reports from the work of the six 
Subcommittee Working Groups that were established on December 12, 2017. 
These subcommittees were established to assist the Working Group with 
the development of the report to Congress and the HHS Secretary as 
required by the 21st Century Cures Act. The subcommittees are:
    1. Disease Vectors, Surveillance and Prevention (includes 
epidemiology of tick-borne diseases);
    2. Pathogenesis, Transmission, and Treatment;
    3. Testing and Diagnostics (including laboratory-based diagnoses 
and clinical-diagnoses);
    4. Access to Care Services and Support to Patients;
    5. Vaccine and Therapeutics; and
    6. Other Tick-Borne Diseases and Co-infections.

DATES: May 10, 2018, from 8:30 a.m. to 6:30 p.m., Eastern Time.

ADDRESSES: This will be a virtual meeting that is held via webcast. 
Members of the public may attend the meeting via webcast. Instructions 
for attending this virtual meeting will be posted one week prior to the 
meeting at: https://www.hhs.gov/ash/advisory-committees/tickbornedisease/.

FOR FURTHER INFORMATION CONTACT: James Berger, Office of HIV/AIDS and 
Infectious Disease Policy, Office of the Assistant Secretary for 
Health, Department of Health and Human Services; via email at 
[email protected] or by phone at 202-795-7697.

SUPPLEMENTARY INFORMATION: The Working Group invites public comment on 
issues related to the Working Group's charge. Comments may be provided 
over the phone during the meeting or in writing. Persons who wish to 
provide comments by phone should review directions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/ before submitting a request via email at 
[email protected] on or before May 3, 2018. Phone comments will 
be limited to three minutes each to accommodate as many speakers as 
possible. A total of 60 minutes will be allocated to public comments. 
If more requests are received than can be accommodated, speakers will 
be randomly selected. The nature of the comments will not be considered 
in making this selection. Public comments may also be provided in 
writing. Individuals who would like to provide written comment should 
review directions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/ before sending their comments to 
[email protected] on or before May 3, 2018.
    Background and Authority: The Tick-Borne Disease Working Group was 
established on August 10, 2017, in accordance with section 2062 of the 
21st Century Cures Act, and the Federal Advisory Committee Act, 5 
U.S.C. App., as amended, to provide expertise and review all HHS 
efforts related to tick-borne diseases to help ensure interagency 
coordination and minimize overlap, examine research priorities, and 
identify and address unmet needs. In addition, the Working Group will 
report to the Secretary and Congress on their findings and any 
recommendations for the federal response to tick-borne disease 
prevention, treatment, and research, and addressing gaps in those 
areas.

    Dated: April 2, 2018.
James Berger,
Office of HIV/AIDS and Infectious Disease Policy, Alternate Designated 
Federal Officer, Tick-Borne Disease Working Group.
[FR Doc. 2018-07217 Filed 4-6-18; 8:45 am]
 BILLING CODE 4150-28-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.